VNDA – vanda pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera [Yahoo! Finance]
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
Form 4 Vanda Pharmaceuticals For: Nov 14 Filed by: Mitchell Stephen Ray
Form 144 Vanda Pharmaceuticals Filed by: Mitchell Stephen Ray
Form 10-Q Vanda Pharmaceuticals For: Sep 30
Form 8-K Vanda Pharmaceuticals For: Nov 06
Form 8-K Vanda Pharmaceuticals For: Oct 14
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.